Quanterix Co. (NASDAQ:QTRX) Director Laurie J. Olson Sells 1,000 Shares of Stock

Quanterix Co. (NASDAQ:QTRXGet Free Report) Director Laurie J. Olson sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $23.50, for a total transaction of $23,500.00. Following the completion of the sale, the director now directly owns 15,238 shares in the company, valued at $358,093. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Quanterix Price Performance

Shares of QTRX opened at $21.81 on Wednesday. Quanterix Co. has a 1 year low of $10.64 and a 1 year high of $29.70. The stock has a 50 day simple moving average of $24.81 and a two-hundred day simple moving average of $24.31. The firm has a market cap of $830.09 million, a P/E ratio of -25.36 and a beta of 1.30.

Quanterix (NASDAQ:QTRXGet Free Report) last announced its quarterly earnings data on Thursday, February 29th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.05). Quanterix had a negative net margin of 26.42% and a negative return on equity of 9.15%. The business had revenue of $31.55 million during the quarter, compared to analysts’ expectations of $27.92 million. On average, equities analysts anticipate that Quanterix Co. will post -1.04 earnings per share for the current year.

Institutional Trading of Quanterix

Several institutional investors have recently added to or reduced their stakes in the business. Advisor Group Holdings Inc. lifted its stake in shares of Quanterix by 184.6% in the 1st quarter. Advisor Group Holdings Inc. now owns 885 shares of the company’s stock valued at $404,000 after acquiring an additional 574 shares during the last quarter. US Bancorp DE lifted its position in Quanterix by 35.6% in the second quarter. US Bancorp DE now owns 1,709 shares of the company’s stock valued at $39,000 after purchasing an additional 449 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of Quanterix by 73.9% during the first quarter. PNC Financial Services Group Inc. now owns 1,845 shares of the company’s stock valued at $53,000 after purchasing an additional 784 shares during the period. Lazard Asset Management LLC bought a new position in shares of Quanterix in the second quarter worth approximately $47,000. Finally, Robeco Institutional Asset Management B.V. purchased a new position in shares of Quanterix in the third quarter worth $67,000. 86.48% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Scotiabank raised their price objective on shares of Quanterix from $30.00 to $32.00 and gave the company a “sector outperform” rating in a research report on Monday, March 4th. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $32.00.

Read Our Latest Research Report on Quanterix

About Quanterix

(Get Free Report)

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

Featured Articles

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.